A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
This article was reviewed by Mike Bohl, MD. If you’ve been using a GLP-1 such as semaglutide, then you’ve likely experienced the powerful effects of this weight loss medication. You’re ...
The drug — the brand name for the GLP-1 agonist semaglutide — “significantly reduced weekly alcohol craving,” according to a study published Wednesday, Feb. 12, in the Journal of the ...
Half received semaglutide, a type of GLP-1 receptor agonist, while the other half received no treatment. Over the nine-week trial, participants taking semaglutide started at a dose of 0.25 mg per ...
Semaglutide is in a class called glucagon-like peptide-1 (GLP-1) receptor agonists ... The recommended maintenance dose of Wegovy is 2.4 milligrams (mg) weekly. But not everyone will need such ...
Eden is providing access to a new way for individuals to explore GLP-1 therapy: a compounded semaglutide gummy, available through independent licensed providers and compounding pharmacies ...
In 2022, when the surge in popularity of the GLP-1 class of weight loss ... two lowest clinical doses of semaglutide, whereas doses for weight reduction reach 2.4 mg/week," the researchers noted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results